Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Center for Genetics at Saint Francis Saint Francis Hospital United States | 1 | 1 |
|
Cystic Fibrosis Common Mutation Panel Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States | 1 | 1 |
|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile | 1 | 1 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 73 | 61 |
|
Cystic Fibrosis Diagnostic Mutation Michigan Medical Genetics Laboratories University of Michigan United States | 1 | 1 |
|
CFTR deletion/duplication analysis Michigan Medical Genetics Laboratories University of Michigan United States | 1 | 1 |
|
Michigan Medical Genetics Laboratories University of Michigan United States | 1 | 1 |
|
CFTR Targeted Mutation Analysis for Cystic Fibrosis Molecular Diagnostics Laboratory Duke University Health System United States | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Cystic Fibrosis (CF) Mutation Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
CFTR sequence of selected exons Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
CFTR - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
TGFB1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 164 |
|
Carrier Screening Ashkenazi Jewish Panel Ambry Genetics United States | 51 | 47 |
|
Ambry Genetics United States | 4 | 2 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.